APG treatment of androgen-refractory human PCa PC3 and DU145 cells resulted in dose-dependent reduction of X-linked inhibitor of apoptosis protein (X-IAP), c-IAP1, c-IAP2, and survivin protein levels. The gene discussed is XIAP; the disease is posterior cortical atrophy.